Adonis RCM Intelligence
Adonis · Ambulatory + facility · SaaS platform
Revenue Cycle / Coding / Prior Auth
AI-native revenue cycle management platform spanning intake, prior authorization, coding, and denials with an embedded intelligence layer and payer connectivity.
Evidence at a glance
Freshness, source-checked counts, confidence and gate results below reflect the frozen evidence snapshot through . A later editorial review does not update these results.
- Stated intended users
- Multi-site provider groups, health systems, MSOs
- Documentary gate at snapshot
- Failed
- Scenario match
- Matches this scenario — Prior-auth automation under CMS-0057-F
- Comparability
- Not yet comparable in this scenario
- Decision readiness at snapshot
- HISTORICAL — Research only
- Documented evidence at snapshot
- 0 of 2 evidence claims source-checked · confidence Low
- Critical unknowns
- scaled production deployment · documented economic outcomes
- Latest checked-source retrieval in snapshot
- not yet measured
Expand each claim to inspect its source, dates and recorded verification status.
independent reportCB Insights profiled Adonis among prior-auth platforms gaining from CMS-0057-F electronic prior authorization deadline (Jan 2027).2026-04-15
Exact claim. CB Insights profiled Adonis among prior-auth platforms gaining from CMS-0057-F electronic prior authorization deadline (Jan 2027).
- Source
- cbinsights.com
- Type
- independent report
- Published
- 2026-04-15
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- deployment_traction
Independent source. Methodology and sample vary by report; read the underlying method.
Open cbinsights.comindependent reportTechTarget RevCycleManagement (Mar 26, 2026) reports Adonis raised a $40M Series C led by Quadrille Capital, bringing total funding to $95M;…2026-03-26
Exact claim. TechTarget RevCycleManagement (Mar 26, 2026) reports Adonis raised a $40M Series C led by Quadrille Capital, bringing total funding to $95M; the company reported four times revenue growth and net retention above 130%, and names Mount Sinai Health System among partnering organisations.
- Source
- techtarget.com
- Type
- independent report
- Published
- 2026-03-26
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- market_durability
- Score contribution
- Feeds market durability
Independent source. Methodology and sample vary by report; read the underlying method.
Open techtarget.comVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands at snapshot (not a 0–100 rank)
Deployment, integration, data handling at snapshot
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- Epic, athenahealth, AdvancedMD, eClinicalWorks
- FHIR / API
- Documented
- SSO
- Supported
- PHI / BAA
- BAA; HIPAA program; PHI-adjacent billing data with least-privilege controls · BAA available
- Security attestations
- SOC 2 Type II, HIPAA
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Platform fee plus performance component; not vendor-confirmed
Technical provenance
snap_36bba25c577cbb44 · Evidence cutoff: 2026-08-27T04:05Z · Snapshot generated: 2026-10-21T19:39Z · build ffbf5c3
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Economic value evidence is UNKNOWN.
Why unknown
Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.
What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.